Stocks and Investing Stocks and Investing
Fri, March 1, 2019
[ 12:00 AM ] - United States, WOPRAI
Michael Nemeroff Maintained (ADSK) at Buy with Increased Target to $175 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Saket Kalia Maintained (ADSK) at Buy with Increased Target to $199 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Nicholas Jones Maintained (CARG) at Strong Buy with Increased Target to $52 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Zack Silver Maintained (CABO) at Strong Buy on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Steven Koenig Maintained (ANSS) at Buy with Increased Target to $201 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Brent Bracelin Maintained (WDAY) at Buy with Increased Target to $235 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Walter Pritchard Maintained (WDAY) at Strong Sell with Increased Target to $138 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Raimo Lenschow Maintained (WDAY) at Hold with Increased Target to $187 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Karl Keirstead Maintained (WDAY) at Hold with Increased Target to $190 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Eric Coldwell Maintained (WBA) at Hold with Decreased Target to $67 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Sarah Akers Maintained (SWX) at Hold with Increased Target to $87 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Jack Meehan Maintained (BIO) at Buy with Increased Target to $340 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Dan Leonard Maintained (BIO) at Strong Buy with Increased Target to $350 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Adam Graf Initiated (SSRM) at Hold on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Joel Beatty Maintained (SRPT) at Strong Buy with Increased Target to $201 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Isaac Ro Upgraded (SRCL) to Strong Buy on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Ralph Giacobbe Maintained (UHS) at Strong Buy with Increased Target to $164 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Peter Costa Maintained (UHS) at Buy with Increased Target to $150 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Christopher Rigg Maintained (UHS) at Strong Buy with Increased Target to $160 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Craig Kucera Downgraded (WSR) to Hold and Decreased Target to $13 on, Mar 1st, 2019
[ 12:00 AM ] - United States, WOPRAI
Adam Graf Initiated (CDE) at Strong Buy on, Mar 1st, 2019
Thu, February 28, 2019
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Silber Maintained (CCRN) at Hold with Decreased Target to $8 on, Feb 28th, 2019
[ 12:00 AM ] - United States, WOPRAI
Steven Halper Maintained (TDOC) at Hold with Decreased Target to $70 on, Feb 28th, 2019
[ 12:00 AM ] - United States, WOPRAI
Spiro Dounis Maintained (TELL) at Buy with Increased Target to $13 on, Feb 28th, 2019
[ 12:00 AM ] - United States, WOPRAI
Steve Enders Downgraded (BOX) to Hold on, Feb 28th, 2019
[ 12:00 AM ] - United States, WOPRAI
Marshall Senk Downgraded (BOX) to Hold on, Feb 28th, 2019
[ 12:00 AM ] - United States, WOPRAI
Rishi Jaluria Maintained (BOX) at Strong Buy with Decreased Target to $25 on, Feb 28th, 2019
[ 12:00 AM ] - United States, WOPRAI
Nick Setyan Maintained (WING) at Buy with Decreased Target to $69 on, Feb 28th, 2019
[ 12:00 AM ] - United States, WOPRAI
Josh Beck Maintained (SQ) at Buy with Decreased Target to $100 on, Feb 28th, 2019
[ 12:00 AM ] - United States, WOPRAI
Christopher Marai Maintained (SRPT) at Strong Buy with Increased Target to $230 on, Feb 28th, 2019

Christopher Marai Maintained (SRPT) at Strong Buy with Increased Target to $230 on, Feb 28th, 2019


Published on 2024-10-26 12:22:54 - WOPRAI, Christopher Marai
  Print publication without navigation


Christopher Marai of Nomura, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Increased Target from $205 to $230 on, Feb 28th, 2019.

Christopher has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Christopher's Rating of Hold.



This is the rating of the analyst that currently disagrees with Christopher

  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $188 on, Tuesday, November 6th, 2018

Contributing Sources